Table 3

Clinical parameters and variants found in HCM patients

GenderAge at diagnosis (years)MLVWT (mm)SCD in familyGeneVar g.Reference sequenceVar c.Var p.PolyPhen2 HumVarPolyPhen2 HumDivGrantham distSIFTAGVGDFreq in EVS (variant alles/wt alleles)Classification*Additional information
Patient 20M???TPM163356265 A>GNM_001018020.1775A>Gp.Lys259GluNot reliableNot reliable560.00C554/10 754VUS2No (not present in transcript NM_000366.5)
Patient 21M6517No
Patient 22F5816YesVCL75854219 G>ANM_014000.21543G>Ap.Gly515SerProbably damagingProbably damaging560.00C55Not foundVUS2No (splicing could be affected)
Patient 23M6215No
Patient 24M7917No
Patient 25M4420?LDB388441437 C>TNM_007078.2566C>Tp.Ser189LeuBenignBenign1450.1C02/10 806VUS3DCM/LVNC family (called S196L), co-segregation in 4 affected members.23 Functionally tested.24 25
MYBPC347354463 T>CNM_000256.33392T>Cp.Ile1131ThrBenignPossibly damaging890.03C557/12 331VUS13 other DCM/NCCM index patients† (one of them together with the pathogenic Dutch founder mutation c.2373dup in MYBPC322; in another family no co-segregation in an affected uncle)
Patient 26M5623No
Patient 27M5019No
Patient 28M6728?TNNT2201328349 C>TNM_000364.2877C>Tp.Arg293CysProbably damagingProbably damaging1800.00C0Not foundVUS33 HCM index patients (called R286C).20 21 3 HCM index patients†
  • Variants in the genes highlighted in bold are variants that were found on top of the variants that were already detected by Sanger sequencing. The variant present in VCL (patient 22) introduced a loss of a splice site on top of the amino acid change.

  • *For further details see Methods section.

  • †Identified in cardiomyopathy patients analysed during routine diagnostics in our laboratory.

  • DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; MLVWT, maximal left ventricular wall thickness; n.a., not available; NCCM, non-compaction cardiomyopathy; SCD, sudden cardiac death; ?, unknown or no exact measurement performed.